These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 34093538)

  • 1. The Expression of Chemokines Is Downregulated in a Pre-Clinical Model of TTR V30M Amyloidosis.
    Moreira J; Costelha S; Saraiva M; Saraiva MJ
    Front Immunol; 2021; 12():650269. PubMed ID: 34093538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR2 and 4 signaling pathways are altered in macrophages from V30M TTR mice with down-regulated expression of chemokines.
    Moreira J; Martins H; Saraiva M; Saraiva MJ
    Clin Sci (Lond); 2023 Mar; 137(5):355-366. PubMed ID: 36852978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inflammatory response to sciatic nerve injury in a familial amyloidotic polyneuropathy mouse model.
    Gonçalves NP; Teixeira-Coelho M; Saraiva MJ
    Exp Neurol; 2014 Jul; 257():76-87. PubMed ID: 24800914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A low amyloidogenic E61K transthyretin mutation may cause familial amyloid polyneuropathy.
    Murakami T; Yokoyama T; Mizuguchi M; Toné S; Takaku S; Sango K; Nishimura H; Watabe K; Sunada Y
    J Neurochem; 2021 Mar; 156(6):957-966. PubMed ID: 32852783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy.
    Taguchi K; Jono H; Kugimiya-Taguchi T; Nagao S; Su Y; Yamasaki K; Mizuguchi M; Maruyama T; Ando Y; Otagiri M
    Life Sci; 2013 Dec; 93(25-26):1017-22. PubMed ID: 24211615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMP-14 overexpression correlates with the neurodegenerative process in familial amyloidotic polyneuropathy.
    Martins D; Moreira J; Gonçalves NP; Saraiva MJ
    Dis Model Mech; 2017 Oct; 10(10):1253-1260. PubMed ID: 28993312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling familial amyloidotic polyneuropathy (Transthyretin V30M) in Drosophila melanogaster.
    Berg I; Thor S; Hammarström P
    Neurodegener Dis; 2009; 6(3):127-38. PubMed ID: 19372706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human transthyretin gene expression is markedly increased in repair Schwann cells in an in vitro model of hereditary transthyretin amyloidosis.
    Murakami T; Ito Y; Sango K; Watabe K; Sunada Y
    Neurochem Int; 2023 Mar; 164():105507. PubMed ID: 36796540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schwann cells contribute to neurodegeneration in transthyretin amyloidosis.
    Murakami T; Sango K; Watabe K; Niimi N; Takaku S; Li Z; Yamamura K; Sunada Y
    J Neurochem; 2015 Jul; 134(1):66-74. PubMed ID: 25693163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of S100A8/A9 in V30M related ATTRv amyloidosis.
    Moreira J; Martins S; Saraiva M; Saraiva MJ
    Amyloid; 2023 Sep; 30(3):327-334. PubMed ID: 36947059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transthyretin gene is expressed in Schwann cells of peripheral nerves.
    Murakami T; Ohsawa Y; Zhenghua L; Yamamura K; Sunada Y
    Brain Res; 2010 Aug; 1348():222-5. PubMed ID: 20547140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of N-glycosylated transthyretin in plasma of V30M carriers in familial amyloidotic polyneuropathy: an escape from ERAD.
    Teixeira AC; Saraiva MJ
    J Cell Mol Med; 2013 Mar; 17(3):429-35. PubMed ID: 23387326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease.
    Adams D; Koike H; Slama M; Coelho T
    Nat Rev Neurol; 2019 Jul; 15(7):387-404. PubMed ID: 31209302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling.
    Sousa MM; Saraiva MJ
    Prog Neurobiol; 2003 Dec; 71(5):385-400. PubMed ID: 14757117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glial cells in familial amyloidotic polyneuropathy.
    Gonçalves NP; Costelha S; Saraiva MJ
    Acta Neuropathol Commun; 2014 Dec; 2():177. PubMed ID: 25519307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective role of anakinra against transthyretin-mediated axonal loss and cell death in a mouse model of familial amyloidotic polyneuropathy.
    Gonçalves NP; Teixeira-Coelho M; Saraiva MJ
    J Neuropathol Exp Neurol; 2015 Mar; 74(3):203-17. PubMed ID: 25668561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial amyloidotic polyneuropathy: protein aggregation in the peripheral nervous system.
    João Saraiva M; Mendes Sousa M; Cardoso I; Fernandes R
    J Mol Neurosci; 2004; 23(1-2):35-40. PubMed ID: 15126690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deposition of transthyretin amyloid is not accelerated by the same amyloid in vivo.
    Wei L; Kawano H; Fu X; Cui D; Ito S; Yamamura K; Ishihara T; Tokuda T; Higuchi K; Maeda S
    Amyloid; 2004 Jun; 11(2):113-20. PubMed ID: 15478467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblasts endocytose and degrade transthyretin aggregates in transthyretin-related amyloidosis.
    Misumi Y; Ando Y; Gonçalves NP; Saraiva MJ
    Lab Invest; 2013 Aug; 93(8):911-20. PubMed ID: 23817086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1 signaling pathway as a therapeutic target in transthyretin amyloidosis.
    Gonçalves NP; Vieira P; Saraiva MJ
    Amyloid; 2014 Sep; 21(3):175-84. PubMed ID: 24918964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.